Drug Shortage Report for APO-DEFERASIROX

Last updated on 2020-05-22 History
Report ID 111901
Drug Identification Number 02461552
Brand name APO-DEFERASIROX
Common or Proper name DEFERASIROX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DEFERASIROX
Strength(s) 250MG
Dosage form(s) TABLET FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 30 BLS
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-06
Estimated end date 2020-05-22
Actual end date 2020-05-21
Shortage status Resolved
Updated date 2020-05-22
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-05-22 French Compare
v5 2020-05-22 English Compare
v4 2020-04-14 French Compare
v3 2020-04-14 English Compare
v2 2020-04-13 French Compare
v1 2020-04-13 English Compare